Anna Halpern, MD

Dr. Anna Halpern MD
Faculty Member

Anna Halpern, MD

Assistant Professor
Clinical Research Division, Fred Hutch

Fax: 206.606.2049
Mail Stop: CE3-300

The focus of Dr. Anna Halpern’s research and patient care is hematologic, or blood, cancers. She develops and tests evidence-based, tailored therapies for adult patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms. Dr. Halpern designs and conducts clinical trials of new treatments and care strategies, and she uses large databases to study broad-scale issues such as risk factors for treatment toxicity. Her goal is to improve outcomes for patients with these diseases.

Other Appointments & Affiliations

Assistant Professor, Division of Hematology and Oncology
Department of Medicine, University of Washington


Hematology-Oncology Fellowship, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, 06/2013-01/2017

Internal Medicine Internship and Residency, University of Chicago Medical Center, Chicago, IL, 06/2009-06/2012

MD, Brown Medical School, Providence, RI, 08/2005-05/2009

AB, Magna Cum Laude, Brown University, Providence, RI, 08/2001-05/2005

Clinical Expertise

Myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN) and acute myeloid leukemia (AML)

Find an Active Clinical Led by Dr. Halpern

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210